SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003711
Filing Date
2018-05-11
Accepted
2018-05-11 14:29:18
Documents
6
Period of Report
2018-06-26
Effectiveness Date
2018-05-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235586zdef14a.htm DEF 14A 642443
2 G733437.JPG g733437.jpg GRAPHIC 11424
3 G424238.JPG g424238.jpg GRAPHIC 4053
4 G202876.JPG g202876.jpg GRAPHIC 7103
5 G112942BCI001.GIF g112942bci001.gif GRAPHIC 142492
6 G112942BCI002.GIF g112942bci002.gif GRAPHIC 85150
  Complete submission text file 0001047469-18-003711.txt   988573
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32966 | Film No.: 18826355
SIC: 2836 Biological Products, (No Diagnostic Substances)